🚀 Do you want to join those shifting industrial chemistry from petrol to green chemistry?
Exapto is a synbio company creating biocomponents with no equivalents know in nature. By integrating those in strains and production processes, Exapto offers disruptive options to both boost existing bioproductions and get to chemicals that were not accessible from renewable resources before.
🌍 This is done by collaborating with leading scientists globally (today Charité in Berlin & DTU in Copenhagen and Ecole Polytechnique, near Paris).
Exapto solutions will provide key foundations for the large scale bio-manufacturing of industry relevant chemicals. Backed international investors, the company has been founded by Philippe Marlière, synbio expert with 100+ patents and cofounder of several companies (2 exits and 1 IPO), together with **Guillaume Dupont,** 20+ years in tech investing and co founder of VC fund Caphorn.
(EN) Senior Scientist / Project leader, Synthetic Biology & Bioproduction (Paris)
(FR) Chercheur / Chef de projet, Biologie synthétique & Bioproduction (Paris)
(EN) Exapto role : Scientist - Strain Engineering (Paris)
(FR) Poste Exapto : Ingénieur - microbiologie (Paris)